TG Therapeutics | TGTX - Debt

Tg Therapeutics reported $71.13M in Debt for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Debt Change
Amgen AMGN:US USD 38.94B 241M
Ardelyx ARDX:US USD 26.71M 170K
Bayer BAYN:GR EUR 41.65B 3.14B
Biogen BIIB:US USD 6.28B 1.8M
Dynavax Technologies DVAX:US USD 221.58M 275K
Intercept Pharmaceuticals ICPT:US USD 332.67M 365K
Karyopharm Therapeutics KPTI:US USD 302.82M 69K
Novartis NOVN:VX USD 27.91B 530M
Novavax NVAX:US USD 549.78M 111.69M
Ptc Therapeutics PTCT:US USD 1.35B 289.13M
Puma Biotechnology PBYI:US USD 98.31M 313K
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Roche Holding ROG:VX 25.35B 2.4B
Tg Therapeutics TGTX:US USD 71.13M 1.1M
Verastem VSTM:US USD 24.8M 134K
Vertex Pharmaceuticals VRTX:US USD 471.6M 29.3M
Ziopharm Oncology ZIOP:US USD 16.76M 5.9M